OVERSEAS FDA Approval ANDA 212688

ANDA 212688

OVERSEAS

FDA Drug Application

Application #212688

Application Sponsors

ANDA 212688OVERSEAS

Marketing Status

Prescription001

Application Products

001TABLET, EXTENDED RELEASE;ORAL750MG0LEVETIRACETAMLEVETIRACETAM

FDA Submissions

UNKNOWN; ORIG1AP2020-06-11STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

OVERSEAS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212688
            [companyName] => OVERSEAS
            [docInserts] => ["",""]
            [products] => [{"drugName":"LEVETIRACETAM","activeIngredients":"LEVETIRACETAM","strength":"750MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/11\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-06-11
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.